Drug delivery nanoparticle composition
AssigneeToyo University
InventorsToru MAEKAWA, Sakthikumar DASAPPAN NAIR, Sheikh Mohamed MOHAMED, Srivani VEERANARAYANAN
Life of this patent
Estimating the term…
Loading patent…
AssigneeToyo University
InventorsToru MAEKAWA, Sakthikumar DASAPPAN NAIR, Sheikh Mohamed MOHAMED, Srivani VEERANARAYANAN
Estimating the term…
Provided is a composition which can be utilized for drug delivery systems that can penetrate the blood brain barrier, and has low cytotoxicity. A nanoparticle composition comprises nanoparticles to the surface of which a first substance and a second substance each having specificity to a tumor cell are bound, wherein the first substance having specificity to the tumor cell is a peptide comprising an amino acid sequence of arginine-glycine-aspartic acid, and wherein the second substance having specificity to the tumor cell is an iron-binding protein, and wherein the nanoparticles each comprise an outer layer and vesicles enveloped by the outer layer and the nanoparticles each comprise, as membrane components, a PEGylated phospholipid, a fatty acid with a melting point of 30° C. or more, and a non-PEGylated phospholipid.
A nanoparticle composition comprising nanoparticles to the surface of which a first substance and a second substance each having specificity to a tumor cell are bound,
A method for producing a nanoparticle composition comprising nanoparticles to the surface of which a first substance and a second substance each having specificity to a tumor cell are bound, comprising:
Dependencies are inferred from the claim text.